MIRMirion Technologies, Inc.

$16.94
On our screens:Stocks with no debt

Price

$16.94-17%1Y
1M+13%1Y-17%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Lagging
2/10
Value22
Quality33
Momentum41
Growth80
Strongest Growth, weakest Value · ranked vs Industrials peers. The five questions below judge the company on its own terms.
What they do

At Mirion, we deliver vital protection that unlocks the transformative potential of radiation to move science, industry and medicine forward. For more than 60 years Mirion and our predecessor companies have provided products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience.

In the company’s own words · 10-K filed Feb 19, 2026 · SEC EDGAR

P/E (TTM)169.4
Market Cap$4.52B
1Y Return-17%
5Y Return+70%

Business segments

Jun 2026 · $266.8M

The company’s own SEC segment disclosure.

  • Nuclear Power$118.1M44%
  • Cancer Care$62.8M24%
  • Other Research$39.0M15%
  • Labs And Research$29.1M11%
  • Other Care$17.8M7%

Mirion Technologies, Inc. (MIR) reported revenue of $258M in Q1 2026 (quarter ended Mar 31, 2026), up 28% from the same quarter a year earlier. That came with a gross margin of 46% and net loss of $3.4M. For the full year FY2025, revenue was $925M (+7.5% year on year) and net income $29M. Its largest product in Jun 2026 was Nuclear Power at $118M, 44% of the disclosed total, well ahead of Cancer Care at 24%.

Raw charts

10 series · TTM

As reported to the SEC, without any scoring.